www.bethelfinance.com
Bethel Finance news:
The retirement of Israel Chemicals Ltd. (TASE: ICL) CEO Akiva Mozes continues to make waves in the Israeli business world, following as it does the resignations of Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) president and CEO Shlomo Yanai and Bank Leumi (TASE: LUMI) president and CEO Galia Maor. Today, Barclays Capital praised Mozes for his performance at Israel Chemicals over the years.
Barclays noted the "apparent suddenness of the move", but added, "While Israeli disclosure rules required the announcement prior to selecting a replacement, we believe that the retirement statement, that Mozes will stay on actively before and after a new CEO is found and that he has been offered a role in the parent company, should allow for as smooth a transition as possible."
Barclays reiterated its "Buy" recommendation for Israel Chemicals. "We would be buyers on weakness as we like the stock at these levels based on fundamentals (which are admittedly mixed in the immediate short run, but strong for the long run) and Israel Chemicals relatively strong position in the sector."
Barclays praised Mozes for his work at Israel Chemicals over the years, saying, "He was instrumental in many of the decisions that have propelled Israel Chemicals from a local player to a large global presence in Israel Chemicals' fertilizer and non-fertilizer businesses."
No comments:
Post a Comment